DoW Lupus, Transformative Vision Development Award
This grant funds early-stage lupus research, including planning and pilot studies, requiring a lupus advocate on the team, and supports future applications for larger interventional studies.
Funder: Dept. of the Army -- USAMRAA
Due Dates: July 29, 2026: Pre-Application (Letter of Intent) | August 19, 2026: Full Application | August 24, 2026: Final Verification
Funding Amounts: Up to $250,000 total costs per award; 2-year maximum period; ~2 awards; total program funding $500,000.
Summary: Supports planning, development, and pilot studies to generate data and feasibility for future lupus interventional research; must address FY26 focus areas and include a lupus consumer advocate.
Key Information: Phase 0/1 clinical trials allowed; phase 2/3 trials and animal studies are not permitted.
Description
This opportunity funds planning, development, and pilot studies that generate preliminary data and demonstrate feasibility for future interventional studies in lupus research. Projects must address at least one of the FY26 Lupus Research Program Transformative Vision Development Award (TVDA) focus areas, with the goal of improving the quality of life for individuals with lupus through innovative interventions at the individual or health care system level. The mechanism permits phase 0/1 clinical trials but does not allow phase 2/3 trials or animal research. Each application must include at least one lupus consumer advocate as an integral member of the research team. Successful projects may serve as a foundation for future applications to the Lupus Research Program Transformative Vision Award (TVA) or equivalent funding opportunities.
